Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.000

€0.000

-83.330%
-0.0015
-83.330%
-
 
13.08.24 / Frankfurt WKN: A1C0DX / Name: SAS / Stock / Passenger Transportation Services / Small Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for SAS

sharewise wants to provide you with the best news and tools for SAS, so we directly link to the best financial data sources.

News

Graphene Investments Liquidates Its $3.1 Million United Rentals Stake
Graphene Investments Liquidates Its $3.1 Million United Rentals Stake

Graphene Investments SAS fully exited its stake in United Rentals (NYSE:URI) in Q3 2025, selling approximately 4,100 shares for an estimated $3.09 million for the period ended 2025-09-30, according

Graphene Investments Sold 115,000 IRDM Shares in Q3 2025
Graphene Investments Sold 115,000 IRDM Shares in Q3 2025

According to a filing with the Securities and Exchange Commission dated October 7, 2025, Graphene Investments SAS sold its entire stake of 115,300 shares in Iridium Communications (NASDAQ:IRDM)

One Wall Street Investment Manager Is Loading Up on Shares of Nasdaq. Is Now the Time to Buy?
One Wall Street Investment Manager Is Loading Up on Shares of Nasdaq. Is Now the Time to Buy?

On October 7, 2025, Graphene Investments SAS disclosed a new position in Nasdaq(NASDAQ:NDAQ), acquiring 37,500 shares in a trade estimated at $3.32 million.

According to a filing with the Securities

SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology
SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology

Marketing approval allows imminent commercialization of the Colovac device in key EU markets

 

PARIS, FRANCE AND TAMPA, FL / ACCESS Newswire / August 14, 2025 / SafeHeal®, a leading innovator